Unconfigured Ad
Collapse
Any topic/question that does not fit into the subcategories below. If you're unsure of where to put something, ask in here!
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by nilshomer, 05-08-2010, 02:19 PM
|
52 responses
118,275 views
0 reactions
|
Last Post
by archana87
04-23-2019, 01:18 PM
|
||
|
Started by Marius, 04-22-2011, 12:10 AM
|
1 response
2,580 views
0 reactions
|
Last Post
by dariober
04-22-2011, 01:37 AM
|
||
|
Started by bbsinfo, 04-19-2011, 04:50 PM
|
5 responses
4,149 views
0 reactions
|
Last Post
by yaximik
04-21-2011, 05:08 AM
|
||
|
Started by JuanLugo, 04-06-2011, 11:15 PM
|
2 responses
3,707 views
0 reactions
|
Last Post
by tonybolger
04-20-2011, 06:34 AM
|
||
|
Started by niceday, 04-20-2011, 02:45 AM
|
0 responses
1,778 views
0 reactions
|
Last Post
by niceday
04-20-2011, 02:45 AM
|
||
|
Started by harrike, 04-14-2011, 09:18 AM
|
1 response
3,395 views
0 reactions
|
Last Post
by mnkyboy
04-14-2011, 09:56 AM
|
||
|
Started by joscarhuguet, 04-13-2011, 12:47 PM
|
0 responses
2,136 views
0 reactions
|
Last Post
by joscarhuguet
04-13-2011, 12:47 PM
|
||
|
Started by asb2718, 04-13-2011, 02:03 AM
|
0 responses
2,785 views
0 reactions
|
Last Post
by asb2718
04-13-2011, 02:03 AM
|
||
|
Started by nivea, 04-12-2011, 07:38 AM
|
0 responses
2,040 views
0 reactions
|
Last Post
by nivea
04-12-2011, 07:38 AM
|
||
|
Started by asb2718, 03-22-2011, 08:55 PM
|
5 responses
5,036 views
0 reactions
|
Last Post
by vbholaiit
04-07-2011, 12:15 AM
|
||
|
Memory usage
by Seta
Started by Seta, 04-05-2011, 05:46 AM
|
2 responses
2,643 views
0 reactions
|
Last Post
by Seta
04-05-2011, 10:44 AM
|
No topics found.
-
Page of 0
No photos found.
-
Page of 0
Webinars
Collapse
-
by SEQadmin2
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...-
Channel: Webinar Series
07-31-2026, 07:00 AM -
Recent Articles
Collapse
-
by SEQadmin2
The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.
This convergence of genetics, immunology, and computation...-
Channel: Articles
Yesterday, 05:41 AM -
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 08-24-2026, 10:32 AM
|
0 responses
47 views
0 reactions
|
Last Post
by SEQadmin2
08-24-2026, 10:32 AM
|
||
|
Started by SEQadmin2, 08-20-2026, 11:17 AM
|
0 responses
49 views
0 reactions
|
Last Post
by SEQadmin2
08-20-2026, 11:17 AM
|
||
|
Started by SEQadmin2, 08-18-2026, 10:05 AM
|
0 responses
55 views
0 reactions
|
Last Post
by SEQadmin2
08-18-2026, 10:05 AM
|